Tranzyme, Inc. (TZYM) Reports In-Line Q1 Loss of 34c/Share

Tranzyme, Inc. (NASDAQ: TZYM) reported Q1 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the quarter came in at $2.61 million versus the consensus estimate of $2.37 million.

For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Optimum Communications gets NYSE non-compliance notice over stock price
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery